Genetic testing for cardiovascular disorders is rapidly expanding, including among children. In its first scientific statement focused on the issue of cardiovascular genetic testing specifically among ...

Cardiovascular testing is a $7.8 billion market, yet for about 30% of patients, their first indication of cardiovascular disease is death, according to the nomination. Myeloperoxidase (MPO), a white ...

The results of a recent retrospective analysis of electronic health record (EHR) data found that only 0.4% of patients with atherosclerotic cardiovascular disease (ASCVD) were tested for lipoprotein(a ...

Cardiovascular genetic testing in children presents unique challenges, requiring pre- and post-test counseling with an individualized approach for families, ideally with the involvement of a ...

Early diagnosis and treatment can contribute to saving or improving people's lives and could help healthcare systems save money Basel, 28 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a ...

Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.

Cardiovascular diagnostic market was valued at $6,876.29 million in 2020, and is projected to reach $15,430.46 million by 2030, registering a CAGR of 8.3% from 2021 to 2030. Cardiovascular diseases ...

It is widely known that cardiovascular diseases (CVD) are one of the leading causes of death. In India, recently the disease burden has been shifting from ...

BDC Laboratories says that the Center for Cardiovascular Translational Science will serve as a hub to drive initiatives in device testing and simulation to serve academic, clinical, and industry ...